Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the
kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and …

Objective Weight loss has been identified as a negative prognostic factor in amyotrophic
lateral sclerosis, but there is no evidence regarding whether a high‐caloric diet increases …

Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disease
primarily affecting motor neurons. We recently identified intermediate-length polyglutamine (polyQ) …

Background Pioglitazone, an oral anti-diabetic that stimulates the PPAR-gamma transcription
factor, increased survival of mice with amyotrophic lateral sclerosis (ALS). Methods/…

Mutations in UBQLN2 have recently been shown to cause dominant X-linked amyotrophic
lateral sclerosis (ALS) and ALS plus frontotemporal dementia (FTD). Information on their …

Weight loss is increasingly considered as a negative prognostic marker in amyotrophic
lateral sclerosis (ALS). Despite the critical importance of nutritional issues in ALS, and the …

Objectives Recent advances in amyotrophic lateral sclerosis (ALS) genetics have revealed
that mutations in any of more than 25 genes can cause ALS, mostly as an autosomal-…

Background Rasagiline, a monoamine oxidase B inhibitor with neuroprotective potential in
Parkinson's disease, has shown a disease-modifying effect in the SOD1-Gly93Ala low-…

Amyotrophic lateral sclerosis, the most common adult-onset motor neuron disease, leads to
death within 3 to 5 years after onset. Beyond progressive motor impairment, patients with …

Background Neurite outgrowth inhibitor A (Nogo-A) is thought to have a role in the
pathophysiology of amyotrophic lateral sclerosis (ALS). A monoclonal antibody against Nogo-A …